Does the U.S. Patent and Trademark Office grant too many bad patents? Evidence from a quasi-experiment.
›
Linked as:Summary
No longer available (Autolink)
See the full content of this document
Extract
Does the U.S. Patent and Trademark Office grant too many bad patents? Evidence from a quasi-experiment.
No longer available (Autolink)
See the full content of this document
This document cites
- Federal Cases - 363 F.Supp.2d 514 (E.D.N.Y. 2005), 1 00MDL1383, In re Ciprofloxacin Hydrochloride Antitrust Litigation
- Federal Cases - 511 F.Supp.2d 652 (E.D.Va. 2007), 1 07cv846, Tafas v. Dudas
- Federal Cases - 541 F.Supp.2d 805 (E.D.Va. 2008), 1 07cv846, Tafas v. Dudas
- Federal Cases - 139 F.3d 1470 (Fed. Cir. 1998), 97-1347, Dow Chemical Co. v. Exxon Corp.
- Federal Cases - 149 F.3d 1368 (Fed. Cir. 1998), 96-1327, State Street Bank & Trust Co. v. Signature Financial Group, Inc
